铁对人体影响的研究进展
Research Progress on the Effects of Iron on Human Body
DOI: 10.12677/acm.2025.153659, PDF,   
作者: 王洪洋, 高 建*：重庆医科大学附属第二医院消化内科，重庆
关键词: 血清铁；心功能；肝功能；认知功能；造血系统；Serum Iron； Cardiac Function； Liver Function； Cognitive Function； Hematopoietic System
摘要: 随着对人体微量元素研究的逐步进展，各种元素对人体的影响逐渐被揭示，其中铁元素作为较为常见的微量元素之一，其对人体各个器官功能的影响受到了越来越多的重视。当人体铁状态失衡时，可能导致铁缺乏或铁超载，此时除了常见的对血液系统的影响外，其对心功能、肝功能、认知功能等全身多器官功能都产生了影响。文章就铁对人体全身多器官功能的影响为主题，总结当前的研究进展，为相应的诊断治疗提供依据。
Abstract: With the gradual progress of research on human trace elements, the influence of various elements on the human body has been gradually revealed, among which iron, as one of the more common trace elements, has received more and more attention on its influence on the function of various organs of the human body. When the iron state of the human body is unbalanced, it may lead to iron deficiency or iron overload. It has an impact on the multi-organ functions of the whole body, such as heart function, liver function, and cognitive function. This paper summarizes the current research progress on the impact of iron on the multi-organ functions of the whole body and provides a basis for the corresponding diagnosis and treatment.
文章引用：王洪洋, 高建. 铁对人体影响的研究进展[J]. 临床医学进展, 2025, 15(3): 645-650. https://doi.org/10.12677/acm.2025.153659

参考文献

[1] Aryal, N., Wood, J., Rijal, I., Deng, D., Jha, M.K. and Ofori-Boadu, A. (2020) Fate of Environmental Pollutants: A Review. Water Environment Research, 92, 1587-1594. [Google Scholar] [CrossRef] [PubMed]
[2] Rolić, T., Yazdani, M., Mandić, S. and Distante, S. (2024) Iron Metabolism, Calcium, Magnesium and Trace Elements: A Review. Biological Trace Element Research. [Google Scholar] [CrossRef] [PubMed]
[3] Berger, M.M., Shenkin, A., Dizdar, O.S., Amrein, K., Augsburger, M., Biesalski, H., et al. (2024) ESPEN Practical Short Micronutrient Guideline. Clinical Nutrition, 43, 825-857. [Google Scholar] [CrossRef] [PubMed]
[4] Ru, Q., Li, Y., Chen, L., Wu, Y., Min, J. and Wang, F. (2024) Iron Homeostasis and Ferroptosis in Human Diseases: Mechanisms and Therapeutic Prospects. Signal Transduction and Targeted Therapy, 9, Article No. 271. [Google Scholar] [CrossRef] [PubMed]
[5] Pasricha, S., Tye-Din, J., Muckenthaler, M.U. and Swinkels, D.W. (2021) Iron Deficiency. The Lancet, 397, 233-248. [Google Scholar] [CrossRef] [PubMed]
[6] Hsu, C.C., Senussi, N.H., Fertrin, K.Y. and Kowdley, K.V. (2022) Iron Overload Disorders. Hepatology Communications, 6, 1842-1854. [Google Scholar] [CrossRef] [PubMed]
[7] Fang, X., Ardehali, H., Min, J. and Wang, F. (2022) The Molecular and Metabolic Landscape of Iron and Ferroptosis in Cardiovascular Disease. Nature Reviews Cardiology, 20, 7-23. [Google Scholar] [CrossRef] [PubMed]
[8] Sawicki, K.T., De Jesus, A. and Ardehali, H. (2023) Iron Metabolism in Cardiovascular Disease: Physiology, Mechanisms, and Therapeutic Targets. Circulation Research, 132, 379-396. [Google Scholar] [CrossRef] [PubMed]
[9] Zhang, J., Song, Y., Li, Y., Lin, H. and Fang, X. (2023) Iron Homeostasis in the Heart: Molecular Mechanisms and Pharmacological Implications. Journal of Molecular and Cellular Cardiology, 174, 15-24. [Google Scholar] [CrossRef] [PubMed]
[10] Wang, C. and Babitt, J.L. (2019) Liver Iron Sensing and Body Iron Homeostasis. Blood, 133, 18-29. [Google Scholar] [CrossRef] [PubMed]
[11] Ameka, M.K. and Hasty, A.H. (2022) Paying the Iron Price: Liver Iron Homeostasis and Metabolic Disease. Comprehensive Physiology, 12, Article 3641.
[12] Leung, A.K.C., Lam, J.M., Wong, A.H.C., Hon, K.L. and Li, X. (2024) Iron Deficiency Anemia: An Updated Review. Current Pediatric Reviews, 20, 339-356. [Google Scholar] [CrossRef] [PubMed]
[13] Vallée, L. (2017) Fer et neurodéveloppement. Archives de Pédiatrie, 24, 5S18-5S22. [Google Scholar] [CrossRef] [PubMed]
[14] David, S., Jhelum, P., Ryan, F., Jeong, S.Y. and Kroner, A. (2022) Dysregulation of Iron Homeostasis in the Central Nervous System and the Role of Ferroptosis in Neurodegenerative Disorders. Antioxidants & Redox Signaling, 37, 150-170. [Google Scholar] [CrossRef] [PubMed]
[15] Manara, R., Ponticorvo, S., Tartaglione, I., Femina, G., Elefante, A., Russo, C., et al. (2019) Brain Iron Content in Systemic Iron Overload: A Beta-Thalassemia Quantitative MRI Study. NeuroImage: Clinical, 24, Article 102058. [Google Scholar] [CrossRef] [PubMed]
[16] 《中国心血管健康与疾病报告2022》要点解读[J]. 中国心血管杂志, 2023, 28(4): 297-312.
[17] 方瑾, 黄鹤. 铁代谢在心肌缺血再灌注损伤及心脏保护中的作用及机制[J]. 医学综述, 2022, 28(6): 1046-1050.
[18] Wahid, M., Islam, S., Sepehrvand, N., Dover, D.C., McAlister, F.A., Kaul, P., et al. (2024) Iron Deficiency, Anemia, and Iron Supplementation in Patients with Heart Failure: A Population-Level Study. Circulation: Heart Failure, 17, e011351. [Google Scholar] [CrossRef] [PubMed]
[19] von Haehling, S., Ebner, N., Evertz, R., Ponikowski, P. and Anker, S.D. (2019) Iron Deficiency in Heart Failure. JACC: Heart Failure, 7, 36-46. [Google Scholar] [CrossRef] [PubMed]
[20] Savarese, G., von Haehling, S., Butler, J., Cleland, J.G.F., Ponikowski, P. and Anker, S.D. (2022) Iron Deficiency and Cardiovascular Disease. European Heart Journal, 44, 14-27. [Google Scholar] [CrossRef] [PubMed]
[21] 方学贤, 蔡昭贤, 王浩, 等. 铁过载及铁死亡在心脏疾病中的研究进展[J]. 科学通报, 2019, 64(Z2): 2974-2987.
[22] Chen, Y., Guo, X., Zeng, Y., Mo, X., Hong, S., He, H., et al. (2023) Oxidative Stress Induces Mitochondrial Iron Overload and Ferroptotic Cell Death. Scientific Reports, 13, Article No. 15515. [Google Scholar] [CrossRef] [PubMed]
[23] Wu, X., Li, Y., Zhang, S. and Zhou, X. (2021) Ferroptosis as a Novel Therapeutic Target for Cardiovascular Disease. Theranostics, 11, 3052-3059. [Google Scholar] [CrossRef] [PubMed]
[24] Siri-Angkul, N., Xie, L., Chattipakorn, S.C. and Chattipakorn, N. (2018) Cellular Electrophysiology of Iron-Overloaded Cardiomyocytes. Frontiers in Physiology, 9, Article 1615. [Google Scholar] [CrossRef] [PubMed]
[25] Sohal, A. and Kowdley, K.V. (2024) A Review of New Concepts in Iron Overload. Gastroenterology & Hepatology, 20, 98-107.
[26] Xu, X., Xu, X., Ma, M., Liang, Y., Cai, Y., Zhu, Z., et al. (2024) The Mechanisms of Ferroptosis and Its Role in Atherosclerosis. Biomedicine & Pharmacotherapy, 171, Article 116112. [Google Scholar] [CrossRef] [PubMed]
[27] Nemeth, E. and Ganz, T. (2021) Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis. International Journal of Molecular Sciences, 22, Article 6493. [Google Scholar] [CrossRef] [PubMed]
[28] Billesbølle, C.B., Azumaya, C.M., Kretsch, R.C., Powers, A.S., Gonen, S., Schneider, S., et al. (2020) Structure of Hepcidin-Bound Ferroportin Reveals Iron Homeostatic Mechanisms. Nature, 586, 807-811. [Google Scholar] [CrossRef] [PubMed]
[29] Siddique, A., Nelson, J.E., Aouizerat, B., Yeh, M.M. and Kowdley, K.V. (2014) Iron Deficiency in Patients with Nonalcoholic Fatty Liver Disease Is Associated with Obesity, Female Gender, and Low Serum Hepcidin. Clinical Gastroenterology and Hepatology, 12, 1170-1178. [Google Scholar] [CrossRef] [PubMed]
[30] Gkamprela, E. (2017) Iron Deficiency Anemia in Chronic Liver Disease: Etiopathogenesis, Diagnosis and Treatment. Annals of Gastroenterology, 30, Article 405. [Google Scholar] [CrossRef] [PubMed]
[31] Sousa, L., Oliveira, M.M., Pessôa, M.T.C. and Barbosa, L.A. (2020) Iron Overload: Effects on Cellular Biochemistry. Clinica Chimica Acta, 504, 180-189. [Google Scholar] [CrossRef] [PubMed]
[32] Nemeth, E. and Ganz, T. (2023) Hepcidin and Iron in Health and Disease. Annual Review of Medicine, 74, 261-277. [Google Scholar] [CrossRef] [PubMed]
[33] Hilgard, P. (2005) Liver Cirrhosis as a Consequence of Iron Overload Caused by Hereditary Nonspherocytic Hemolytic Anemia. World Journal of Gastroenterology, 11, 1241-1244. [Google Scholar] [CrossRef] [PubMed]
[34] Datz, C., Müller, E. and Aigner, E. (2017) Iron Overload and Non-Alcoholic Fatty Liver Disease. Minerva Endocrinology, 42, 173-183. [Google Scholar] [CrossRef] [PubMed]
[35] Honma, K., Kirihara, S., Nakayama, H., Fukuoka, T., Ohara, T., Kitamori, K., et al. (2023) Selective Autophagy Associated with Iron Overload Aggravates Non-Alcoholic Steatohepatitis via Ferroptosis. Experimental Biology and Medicine, 248, 1112-1123. [Google Scholar] [CrossRef] [PubMed]
[36] Hino, K., Yanatori, I., Hara, Y. and Nishina, S. (2021) Iron and Liver Cancer: An Inseparable Connection. The FEBS Journal, 289, 7810-7829. [Google Scholar] [CrossRef] [PubMed]
[37] Kowdley, K.V., Brown, K.E., Ahn, J. and Sundaram, V. (2019) ACG Clinical Guideline: Hereditary Hemochromatosis. American Journal of Gastroenterology, 114, 1202-1218. [Google Scholar] [CrossRef] [PubMed]
[38] Murphree, C.R., Nguyen, N.N., Raghunathan, V., Olson, S.R., DeLoughery, T. and Shatzel, J.J. (2020) Diagnosis and Management of Hereditary Haemochromatosis. Vox Sanguinis, 115, 255-262. [Google Scholar] [CrossRef] [PubMed]
[39] Kumar, A., Sharma, E., Marley, A., Samaan, M.A. and Brookes, M.J. (2022) Iron Deficiency Anaemia: Pathophysiology, Assessment, Practical Management. BMJ Open Gastroenterology, 9, e000759. [Google Scholar] [CrossRef] [PubMed]
[40] Chaparro, C.M. and Suchdev, P.S. (2019) Anemia Epidemiology, Pathophysiology, and Etiology in Low and Middle-Income Countries. Annals of the New York Academy of Sciences, 1450, 15-31. [Google Scholar] [CrossRef] [PubMed]
[41] Lo, J.O., Benson, A.E., Martens, K.L., Hedges, M.A., McMurry, H.S., DeLoughery, T., et al. (2022) The Role of Oral Iron in the Treatment of Adults with Iron Deficiency. European Journal of Haematology, 110, 123-130. [Google Scholar] [CrossRef] [PubMed]
[42] 刘旭, 刘文虎. 脑铁沉积与衰老关系的研究进展[J]. 中华老年多器官疾病杂志, 2023, 22(7): 546-549.
[43] 买孝林, 曹成珠, 王海燕, 等. 铁死亡调控机制及在神经系统相关疾病中的研究进展[J]. 中国临床药学杂志, 2024, 33(12): 947-954.
[44] McWilliams, S., Singh, I., Leung, W., Stockler, S. and Ipsiroglu, O.S. (2022) Iron Deficiency and Common Neurodevelopmental Disorders—A Scoping Review. PLOS ONE, 17, e0273819. [Google Scholar] [CrossRef] [PubMed]
[45] Ding, X., Gao, L., Han, Z., Eleuteri, S., Shi, W., Shen, Y., et al. (2023) Ferroptosis in Parkinson’s Disease: Molecular Mechanisms and Therapeutic Potential. Ageing Research Reviews, 91, Article 102077. [Google Scholar] [CrossRef] [PubMed]
[46] 王雨朔, 孟凡超. 铁元素与帕金森病研究进展[J]. 中国实用神经疾病杂志, 2021, 24(16): 1465-1472.
[47] Peng, Y., Chang, X. and Lang, M. (2021) Iron Homeostasis Disorder and Alzheimer’s Disease. International Journal of Molecular Sciences, 22, Article 12442. [Google Scholar] [CrossRef] [PubMed]
[48] Wang, J., Fu, J., Zhao, Y., Liu, Q., Yan, X. and Su, J. (2023) Iron and Targeted Iron Therapy in Alzheimer’s Disease. International Journal of Molecular Sciences, 24, Article 16353. [Google Scholar] [CrossRef] [PubMed]
[49] Teh, M.R., Armitage, A.E. and Drakesmith, H. (2024) Why Cells Need Iron: A Compendium of Iron Utilisation. Trends in Endocrinology & Metabolism, 35, 1026-1049. [Google Scholar] [CrossRef] [PubMed]
[50] Abbasi, U., Abbina, S., Gill, A., Takuechi, L.E. and Kizhakkedathu, J.N. (2021) Role of Iron in the Molecular Pathogenesis of Diseases and Therapeutic Opportunities. ACS Chemical Biology, 16, 945-972. [Google Scholar] [CrossRef] [PubMed]
[51] Man, Y., Xu, T., Adhikari, B., Zhou, C., Wang, Y. and Wang, B. (2021) Iron Supplementation and Iron-Fortified Foods: A Review. Critical Reviews in Food Science and Nutrition, 62, 4504-4525. [Google Scholar] [CrossRef] [PubMed]
[52] Bruzzese, A., Martino, E.A., Mendicino, F., Lucia, E., Olivito, V., Bova, C., et al. (2023) Iron Chelation Therapy. European Journal of Haematology, 110, 490-497. [Google Scholar] [CrossRef] [PubMed]

为你推荐